Inhibrx Biosciences, Inc. (INBX) — SC 13D Filings
All SC 13D filings from Inhibrx Biosciences, Inc.. Browse 1 Activist Stake Filing reports with AI-powered summaries and risk analysis.
SC 13D Filings (1)
-
Mark Lappe Files 13D for Inhibrx Biosciences
— Jun 3, 2024 Risk: medium
Mark Lappe filed a Schedule 13D on June 3, 2024, regarding his beneficial ownership of Inhibrx Biosciences, Inc. The filing indicates a change in reporting as o
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX